相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。17β-estradiol at low concentrations attenuates the efficacy of tamoxifen in breast cancer therapy
Zhixiang Xu et al.
ENVIRONMENTAL POLLUTION (2019)
Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells
Qiang Wang et al.
CELL RESEARCH (2018)
Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities
Hillary Stires et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes
Zhixiang Xu et al.
TOXICOLOGY (2018)
Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro
Wenwen Gu et al.
CELL BIOLOGY AND TOXICOLOGY (2017)
Biological effects of xenoestrogens and the functional mechanisms via genomic and nongenomic pathways
Zhi-Xiang Xu et al.
ENVIRONMENTAL REVIEWS (2017)
GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis
Heng Yin et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Emerging functional roles of nuclear receptors in breast cancer
Tram B. Doan et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)
Pitaya Extracts Induce Growth Inhibition and Proapoptotic Effects on Human Cell Lines of Breast Cancer via Downregulation of Estrogen Receptor Gene Expression
Deborah de Almeida Bauer Guimaraes et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Biological effects of xenoestrogens and the functional mechanisms via genomic and nongenomic pathways
Zhi-Xiang Xu et al.
ENVIRONMENTAL REVIEWS (2017)
The p53/p21 Complex Regulates Cancer Cell Invasion and Apoptosis by Targeting Bcl-2 Family Proteins
Eun Mi Kim et al.
CANCER RESEARCH (2017)
ER-α36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells
Qing Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Sensitization of estrogen receptor-positive breast cancer cell lines to 4-hydroxytamoxifen by isothiocyanates present in cruciferous plants
Anna Pawlik et al.
EUROPEAN JOURNAL OF NUTRITION (2016)
An in vitro model for the development of acquired tamoxifen resistance
Gamze Guney Eskiler et al.
CELL BIOLOGY AND TOXICOLOGY (2016)
p53-dependent apoptosis contributes to di-(2-ethylhexyl) phthalate-induced hepatotoxicity
Mei Ha et al.
ENVIRONMENTAL POLLUTION (2016)
ERα36-Another piece of the estrogen puzzle
Kamil Soltysik et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2015)
The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents
Daniel Gabriel Pons et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer
Zhao-Yi Wang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Endocrine resistance in breast cancer - An overview and update
Robert Clarke et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Role of ER-α36 in breast cancer by typical xenoestrogens
Jun Liu et al.
TUMOR BIOLOGY (2015)
Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer
Congwen Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A bi-faceted role of estrogen receptor β in breast cancer
Etienne Leygue et al.
ENDOCRINE-RELATED CANCER (2013)
Estrogen Receptor-α Variant, ER-α36, is Involved in Tamoxifen Resistance and Estrogen Hypersensitivity
XianTian Zhang et al.
ENDOCRINOLOGY (2013)
Occurrence, removal and bioaccumulation of steroid estrogens in Dianchi Lake catchment, China
Bin Huang et al.
ENVIRONMENT INTERNATIONAL (2013)
Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
Rocio Garcia-Becerra et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Research Resource: Nuclear Receptors as Transcriptome: Discriminant and Prognostic Value in Breast Cancer
George E. O. Muscat et al.
MOLECULAR ENDOCRINOLOGY (2013)
Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells
Guangliang Li et al.
MOLECULAR ONCOLOGY (2013)
An in vitro comparison study: The effects of fetal bovine serum concentration on retinal progenitor cell multipotentiality
Yamin Hu et al.
NEUROSCIENCE LETTERS (2013)
Apoptosis and necrosis of human breast cancer cells by an aqueous extract of garden cress (Lepidium sativum) seeds
Sawsan Hassan Mahassni et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2013)
GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells
Adele Vivacqua et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression
Bin Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Membrane Estrogen Signaling Enhances Tumorigenesis and Metastatic Potential of Breast Cancer Cells via Estrogen Receptor-α36 (ERα36)
Reyhaan A. Chaudhri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Alternate Estrogen Receptors Promote Invasion of Inflammatory Breast Cancer Cells via Non-Genomic Signaling
Kazufumi Ohshiro et al.
PLOS ONE (2012)
Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells
John J. Tyson et al.
NATURE REVIEWS CANCER (2011)
Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells
Atanas Ignatov et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrest
Q. K. Y. Chan et al.
CELL DEATH AND DIFFERENTIATION (2010)
Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells
Soo Jin Oh et al.
FOOD AND CHEMICAL TOXICOLOGY (2010)
American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells
Takako Sakamoto et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2010)
ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways
Sheng-Li Lin et al.
PLOS ONE (2010)
G protein-coupled receptor 30 in tumor development
Dengfeng Wang et al.
ENDOCRINE (2010)
Gambogic acid down-regulates MDM2 oncogene and induces p21Waf1/CIP1 expression independent of p53
Jing-Jing Rong et al.
CANCER LETTERS (2009)
Estrogen receptor-alpha (ER-α) suppresses expression of its variant ER-α36
Yi Zou et al.
FEBS LETTERS (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells
Jianli Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Long-term exposure to tamoxifen induces hypersensitivity to estradiol
LM Berstein et al.
CLINICAL CANCER RESEARCH (2004)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Regulation of the G2/M transition by p53
WR Taylor et al.
ONCOGENE (2001)
分享论文
